Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glycomimetics Inc
(NQ:
GLYC
)
0.1648
-0.0052 (-3.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Glycomimetics Inc
< Previous
1
2
3
4
Next >
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 26, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Via
InvestorPlace
Why GlycoMimetics Stock is Trading Higher Monday
June 25, 2024
On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305 thousand shares in the company.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via
InvestorPlace
Earnings Outlook For GlycoMimetics
March 26, 2024
Via
Benzinga
Earnings Outlook For GlycoMimetics
November 02, 2023
Via
Benzinga
GlycoMimetics: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Earnings Preview For GlycoMimetics
March 28, 2023
Via
Benzinga
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
June 21, 2024
Via
Benzinga
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
May 09, 2024
GLYC stock results show that GlycoMimetics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
May 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
May 06, 2024
Via
Benzinga
Exposures
Fossil Fuels
12 Health Care Stocks Moving In Monday's Intraday Session
May 06, 2024
Via
Benzinga
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
May 06, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
GlycoMimetics' Uproleselan Flunks In Late Stage Leukemia Study, Shares Sink
May 06, 2024
Get insights on GlycoMimetics Inc's Phase 3 study results for uproleselan in R/R AML patients. Explore survival rates, adverse events, and future analyses.
Via
Benzinga
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
May 06, 2024
Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week.
Via
InvestorPlace
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
May 06, 2024
GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 06, 2024
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 27, 2024
Via
Benzinga
GLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023
March 27, 2024
GLYC stock results show that GlycoMimetics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
GlycoMimetics: A Potential Game Changer In Blood Cancers With Near-Term Catalysts
March 21, 2024
Glycomimetics' Uproleselan is expected to read out data in relapsed/refractory and elderly newly diagnosed Acute Myeloid Leukemia (AML) after 6 years in pivotal studies.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 24, 2024
Via
Benzinga
Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
January 03, 2024
Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan....
Via
Benzinga
Earnings Scheduled For November 3, 2023
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
May 09, 2023
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.